Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome

References

• El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. 2012;18:5151–5163.
   PubMed Web of Science ®Google Scholar
• El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2015;21:7621–7636.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hausken T, Gilja OH, et al. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2017;11:139–148.
   PubMed Web of Science ®Google Scholar
• Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther. 2004;19:1217–1224.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009;24:1601–1607.
   PubMed Web of Science ®Google Scholar
• Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27:22–28.
   PubMedGoogle Scholar
• Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225–235.
   PubMed Web of Science ®Google Scholar
• Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol. 2000;95:3176–3183.
   PubMed Web of Science ®Google Scholar
• Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001;36:1155–1161.
   PubMed Web of Science ®Google Scholar
• Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol. 2003;22:215–216.
   PubMedGoogle Scholar
• Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001;20:103–106.
   PubMedGoogle Scholar
• El-Salhy M, Gundersen D, Gilja OH, et al. Is irritable bowel syndrome an organic disorder? World J Gastroenterol. 2014;20:384–400.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Seim I, Chopin L, et al. Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed). 2012;4:2783–2800.
   PubMedGoogle Scholar
• El-Salhy M, Hatlebakk JG, Hausken T. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol. 2015;21:9577–9587.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome. BMC Gastroenterol. 2017;17:90.
   PubMed Web of Science ®Google Scholar
• Montgomery RK, Breault DT. Small intestinal stem cell markers. J Anat. 2008;213:52–58.
   PubMed Web of Science ®Google Scholar
• Potten CS, Booth C, Tudor GL, et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation. 2003;71:28–41.
   PubMed Web of Science ®Google Scholar
• Kayahara T, Sawada M, Takaishi S, et al. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett. 2003;535:131–135.
   PubMed Web of Science ®Google Scholar
• Wang J, Cortina G, Wu SV, et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med. 2006;355:270–280.
   PubMed Web of Science ®Google Scholar
• Jenny M, Uhl C, Roche C, et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 2002;21:6338–6347.
   PubMed Web of Science ®Google Scholar
• Lee CS, Perreault N, Brestelli JE, et al. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev. 2002;16:1488–1497.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Danielsson A, Stenling R, et al. Colonic endocrine cells in inflammatory bowel disease. J Intern Med. 1997;242:413–419.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Hausken T, et al. Interaction between diet and gastrointestinal endocrine cells. Biomed Rep. 2016;4:651–656.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Sandstrom O, Nasstrom E, et al. Application of computer image analysis in endocrine cell quantification. Histochem J. 1997;29:249–256.
   PubMedGoogle Scholar
• El-Salhy M, Patcharatrakul T, Hatlebakk JG, et al. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome. Scand J Gastroenterol. 2017;52:691–697.
   PubMed Web of Science ®Google Scholar
• Gershon MD. Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol. 2003;3:600–607.
   PubMed Web of Science ®Google Scholar
• Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20:14–21.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, et al. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome. Peptides. 2015;67:12–19.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Trotman IF, Adrian TE, et al. Further characterisation of the ‘ileal brake’ reflex in man–effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut. 1988;29:1042–1051.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Trotman IF, Higgins BE, et al. The ileal brake–inhibition of jejunal motility after ileal fat perfusion in man. Gut. 1984;25:365–374.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Grimelius L, Wilander E, et al. Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract. Histochemistry. 1983;77:15–23.
   PubMedGoogle Scholar
• Spangeus A, Forsgren S, el-Salhy M. Does diabetic state affect co-localization of peptide YY and enteroglucagon in colonic endocrine cells? Histol Histopathol. 2000;15:37–41.
   PubMed Web of Science ®Google Scholar
• Barker N, Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology. 2007;133:1755–1760.
   PubMed Web of Science ®Google Scholar
• Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev. 2008;22:1856–1864.
   PubMed Web of Science ®Google Scholar
• Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat. 1974;141:537–561.
   PubMedGoogle Scholar
• He XC, Yin T, Grindley JC, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet. 2007;39:189–198.
   PubMed Web of Science ®Google Scholar
• Fishbein TM, Novitskiy G, Lough DM, et al. Rejection reversibly alters enteroendocrine cell renewal in the transplanted small intestine. Am J Transplant. 2009;9:1620–1628.
   PubMed Web of Science ®Google Scholar
• Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: development and differentiation of gut endocrine cells. Endocrinology. 2004;145:2639–2644.
   PubMed Web of Science ®Google Scholar
• Schonhoff SE, Giel-Moloney M, Leiter AB. Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev Biol. 2004;270:443–454.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Gundersen D, et al. Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterol Res Pract. 2014;2014:462856.
   PubMed Web of Science ®Google Scholar
• Unlusoy AA, Egritas Gurkan O, Sari S, et al. Mutant neurogenin-3 in a Turkish boy with congenital malabsorptive diarrhea. Pediatr Int. 2016;58:379–382.
   PubMed Web of Science ®Google Scholar
• Jensen JN, Rosenberg LC, Hecksher-Sorensen J, et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med. 2007;356:1781–1782.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Gundersen D, et al. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep. 2012;6:1223–1225.
   PubMed Web of Science ®Google Scholar
• Svendsen B, Holst JJ. Regulation of gut hormone secretion. Studies using isolated perfused intestines. Peptides. 2016;77:47–53.
   PubMed Web of Science ®Google Scholar
• Svendsen B, Pedersen J, Albrechtsen NJ, et al. An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine. Endocrinology. 2015;156:847–857.
   PubMed Web of Science ®Google Scholar
• Egerod KL, Engelstoft MS, Grunddal KV, et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012;153:5782–5795.
   PubMed Web of Science ®Google Scholar